Companion Spine LLC, the France-USA specialist in diagnostic and interventional spine surgery, has raised USD55 million inna Series A financing led by Viscogliosi Brothers, the company’s co-founder and historical shareholder, and jointly invested by a global medical technology company.
Viscogliosi Brothers initiated and formed Companion Spine to focus on spine pain treatment, motion preservation, precision diagnostics and interventional care to allow for a comprehensive spine health and a total spine care continuum approach for patients, spine pain specialists, treatment centres and payors.
The funds raised will be used primarily for the development and commercialisation of Companion Spine’s range of minimally invasive diagnostic and therapeutic solutions in the United States and internationally for the treatment of the two main indications targeted by the company: Degenerative Disc Disease (DDD) and Lumbar Spine Stenosis (LSS), two of the most common spine diseases in the world, with more than 10 million potential cases identified in the United States alone including several million patients suffering from severe back pain without an effective therapeutic solution.
